MedAssets Price Target Raised to $30.00 at Jefferies Group (MDAS)
Stock analysts at Jefferies Group boosted their price target on shares of MedAssets (NASDAQ:MDAS) from $25.00 to $30.00 in a report issued on Thursday, American Banking News reports. The firm currently has a “buy” rating on the stock. Jefferies Group’s price target would suggest a potential upside of 30.27% from the stock’s previous close.
A number of other firms have also recently commented on MDAS. Analysts at FBR & Co. initiated coverage on shares of MedAssets in a research note to investors on Thursday. They set a “market perform” rating on the stock. Separately, analysts at FBR Capital Markets initiated coverage on shares of MedAssets in a research note to investors on Thursday. They set a “market perform” rating and a $24.00 price target on the stock. Finally, analysts at ISI Group downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note to investors on Thursday. They now have a $26.00 price target on the stock, down previously from $28.00. Eight research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. MedAssets has a consensus rating of “Hold” and an average price target of $26.98.
In other MedAssets news, CAO Lance M. Culbreth sold 2,000 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $26.45, for a total value of $52,900.00. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of MedAssets (NASDAQ:MDAS) traded down 11.66% on Thursday, hitting $23.029. The stock had a trading volume of 2,916,745 shares. MedAssets has a 52 week low of $15.40 and a 52 week high of $24.52. The stock has a 50-day moving average of $25.13 and a 200-day moving average of $21.09. The company has a market cap of $1.409 billion and a P/E ratio of 389.10.
MedAssets (NASDAQ:MDAS) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.31 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.30 by $0.01. The company had revenue of $166.40 million for the quarter, compared to the consensus estimate of $166.78 million. During the same quarter in the prior year, the company posted $0.32 earnings per share. The company’s quarterly revenue was up 1.8% on a year-over-year basis. On average, analysts predict that MedAssets will post $1.32 earnings per share for the current fiscal year.
MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.